Trium Capital LLP Quanterix Corp Transaction History
Trium Capital LLP
- $830 Million
- Q2 2025
A detailed history of Trium Capital LLP transactions in Quanterix Corp stock. As of the latest transaction made, Trium Capital LLP holds 586,425 shares of QTRX stock, worth $3.45 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
586,425
Previous 559,500
4.81%
Holding current value
$3.45 Million
Previous $3.64 Million
7.06%
% of portfolio
0.47%
Previous 0.45%
Shares
2 transactions
Others Institutions Holding QTRX
# of Institutions
145Shares Held
35.4MCall Options Held
0Put Options Held
0-
Ameriprise Financial Inc Minneapolis, MN4.24MShares$24.9 Million0.01% of portfolio
-
Portolan Capital Management, LLC Boston, MA3.63MShares$21.4 Million1.75% of portfolio
-
Black Rock Inc. New York, NY3.14MShares$18.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.53MShares$14.9 Million0.0% of portfolio
-
Kent Lake Pr LLC Anasco, PR2.3MShares$13.5 Million6.75% of portfolio
About Quanterix Corp
- Ticker QTRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,987,600
- Market Cap $217M
- Description
- Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...